Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

HIV Infection

Free Subscription Articles published in Nature Retrieve available abstracts of 51 articles: HTML format

Single Articles

November 2023
1. DAM KA, Fan C, Yang Z, Bjorkman PJ, et al
   Intermediate conformations of CD4-bound HIV-1 Env heterotrimers.
   Nature. 2023 Nov 22. doi: 10.1038/s41586-023-06639.
   PubMed     Abstract available
   
   
   
2. LI W, Qin Z, Nand E, Grunst MW, et al
   HIV-1 Env trimers asymmetrically engage CD4 receptors in membranes.
   Nature. 2023 Nov 22. doi: 10.1038/s41586-023-06762.
   PubMed     Abstract available
   
   
   
3. LE VOYER T, Parent AV, Liu X, Cederholm A, et al
   Autoantibodies against type I IFNs in humans with alternative NF-kappaB pathway deficiency.
   Nature. 2023 Nov 8. doi: 10.1038/s41586-023-06717.
   PubMed     Abstract available
   
   
   
4. NKENGASONG J, Reid M, Katz IT
   This is how the world finally ends the HIV/AIDS pandemic.
   Nature. 2023;623:907-909.
   PubMed    
   
   
   October 2023
5. 
   Hope rises that a vaccine can shield people with HIV from a deadly threat.
   Nature. 2023 Oct 18. doi: 10.1038/d41586-023-03220.
   PubMed    
   
   
   
6. THADANI NN, Gurev S, Notin P, Youssef N, et al
   Learning from prepandemic data to forecast viral escape.
   Nature. 2023 Oct 11. doi: 10.1038/s41586-023-06617.
   PubMed     Abstract available
   
   
   September 2023
7. MCLAREN PJ, Porreca I, Iaconis G, Mok HP, et al
   Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load.
   Nature. 2023 Sep 5. doi: 10.1038/s41586-023-06591.
   PubMed    
   
   
   August 2023
8. ZHAO Y, Lu Y, Richardson S, Sreekumar M, et al
   TRIM5alpha restricts poxviruses and is antagonized by CypA and the viral protein C6.
   Nature. 2023 Aug 9. doi: 10.1038/s41586-023-06401.
   PubMed     Abstract available
   
   
   
9. MCLAREN PJ, Porreca I, Iaconis G, Mok HP, et al
   Africa-specific human genetic variation near CHD1L associates with HIV-1 load.
   Nature. 2023 Aug 2. doi: 10.1038/s41586-023-06370.
   PubMed     Abstract available
   
   
   
10. 
    Variation in African genomes linked to control of HIV.
    Nature. 2023 Aug 2. doi: 10.1038/d41586-023-02277.
    PubMed    
    
    
    July 2023
11. AUGUSTO DG, Murdolo LD, Chatzileontiadou DSM, Sabatino JJ Jr, et al
    A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.
    Nature. 2023 Jul 19. doi: 10.1038/s41586-023-06331.
    PubMed     Abstract available
    
    
    May 2023
12. KEN ML, Roy R, Geng A, Ganser LR, et al
    RNA conformational propensities determine cellular activity.
    Nature. 2023 May 17. doi: 10.1038/s41586-023-06080.
    PubMed     Abstract available
    
    
    February 2023
13. GRAHAM F
    Daily briefing: A third person is HIV-free after stem-cell transplant.
    Nature. 2023 Feb 21. doi: 10.1038/d41586-023-00534.
    PubMed    
    
    
    
14. REARDON S
    Third patient free of HIV after receiving virus-resistant cells.
    Nature. 2023 Feb 21. doi: 10.1038/d41586-023-00479.
    PubMed    
    
    
    
15. LI YL, Langley CA, Azumaya CM, Echeverria I, et al
    The structural basis for HIV-1 Vif antagonism of human APOBEC3G.
    Nature. 2023 Feb 8. doi: 10.1038/s41586-023-05779.
    PubMed     Abstract available
    
    
    January 2023
16. LEE JH, Sutton HJ, Cottrell CA, Phung I, et al
    Author Correction: Long-primed germinal centres with enduring affinity maturation and clonal migration.
    Nature. 2023 Jan 30:1. doi: 10.1038/s41586-023-05741.
    PubMed    
    
    
    
17. CHOMONT N
    Silence, escape and survival drive the persistence of HIV.
    Nature. 2023 Jan 4. doi: 10.1038/d41586-022-04492.
    PubMed    
    
    
    
18. CLARK IC, Mudvari P, Thaploo S, Smith S, et al
    HIV silencing and cell survival signatures in infected T cell reservoirs.
    Nature. 2023 Jan 4. doi: 10.1038/s41586-022-05556.
    PubMed     Abstract available
    
    
    
19. SUN W, Gao C, Hartana CA, Osborn MR, et al
    Phenotypic signatures of immune selection in HIV-1 reservoir cells.
    Nature. 2023 Jan 4. doi: 10.1038/s41586-022-05538.
    PubMed     Abstract available
    
    
    December 2022
20. CAO Y, Jian F, Wang J, Yu Y, et al
    Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution.
    Nature. 2022 Dec 19. doi: 10.1038/s41586-022-05644.
    PubMed     Abstract available
    
    
    October 2022
21. 
    Laggard rich countries risk slowing the fight against AIDS, malaria and TB.
    Nature. 2022;610:8.
    PubMed    
    
    
    September 2022
22. LEE JH, Sutton HJ, Cottrell CA, Phung I, et al
    Long-primed germinal centres with enduring affinity maturation and clonal migration.
    Nature. 2022 Sep 21. pii: 10.1038/s41586-022-05216.
    PubMed     Abstract available
    
    
    
23. GONSALVES G
    Monkeypox, COVID-19, AIDS: have we progressed so little?
    Nature. 2022;609:443.
    PubMed    
    
    
    August 2022
24. PADMA TV
    Long-lasting HIV prevention drug could be game changer - but who will pay?
    Nature. 2022 Aug 5. pii: 10.1038/d41586-022-02123.
    PubMed    
    
    
    
25. 
    Preventive HIV drug shows urgent need for transparency on pricing.
    Nature. 2022;608:239.
    PubMed    
    
    
    July 2022
26. 
    Small payments to low-income people lead to big drops in HIV deaths.
    Nature. 2022;607:639.
    PubMed    
    
    
    June 2022
27. CAO Y, Yisimayi A, Jian F, Song W, et al
    BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
    Nature. 2022 Jun 17. pii: 10.1038/s41586-022-04980.
    PubMed     Abstract available
    
    
    
28. SNELLER MC, Blazkova J, Justement JS, Shi V, et al
    Combination anti-HIV antibodies provide sustained virological suppression.
    Nature. 2022 Jun 1. pii: 10.1038/s41586-022-04797.
    PubMed     Abstract available
    
    
    May 2022
29. SHEN Y, Zhou M, Cai D, Filho DA, et al
    CCR5 closes the temporal window for memory linking.
    Nature. 2022 May 25. pii: 10.1038/s41586-022-04783.
    PubMed     Abstract available
    
    
    
30. SURYAWANSHI RK, Chen IP, Ma T, Syed AM, et al
    Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination.
    Nature. 2022 May 18. pii: 10.1038/s41586-022-04865.
    PubMed     Abstract available
    
    
    
31. URAKI R, Kiso M, Iida S, Imai M, et al
    Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2.
    Nature. 2022 May 16. pii: 10.1038/s41586-022-04856.
    PubMed     Abstract available
    
    
    
32. MALEBRANCHE D
    HIV Care Has Improved Dramatically-But Not for Everyone.
    Nature. 2022;605:S24-S25.
    PubMed    
    
    
    April 2022
33. GAEBLER C, Nogueira L, Stoffel E, Oliveira TY, et al
    Prolonged viral suppression with anti-HIV-1 antibody therapy.
    Nature. 2022 Apr 13. pii: 10.1038/s41586-022-04597.
    PubMed     Abstract available
    
    
    
34. KEETON R, Tincho MB, Ngomti A, Baguma R, et al
    Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize Omicron.
    Nature. 2022 Apr 8. pii: 10.1038/s41586-022-04708.
    PubMed    
    
    
    March 2022
35. DEGRACE MM, Ghedin E, Frieman MB, Krammer F, et al
    Defining the risk of SARS-CoV-2 variants on immune protection.
    Nature. 2022 Mar 31. pii: 10.1038/s41586-022-04690.
    PubMed     Abstract available
    
    
    
36. ROBERTS L
    Surge of HIV, tuberculosis and COVID feared amid war in Ukraine.
    Nature. 2022 Mar 15. pii: 10.1038/d41586-022-00748.
    PubMed    
    
    
    
37. LEDFORD H
    Luc Montagnier (1932-2022).
    Nature. 2022;603:223.
    PubMed    
    
    
    February 2022
38. GRAHAM F
    Daily briefing: Woman cleared of HIV after transplant with umbilical-cord blood.
    Nature. 2022 Feb 16. pii: 10.1038/d41586-022-00483.
    PubMed    
    
    
    
39. GRAHAM F
    Daily briefing: Highly virulent HIV variant circulating in Europe.
    Nature. 2022 Feb 4. pii: 10.1038/d41586-022-00362.
    PubMed    
    
    
    
40. GUGLIELMI G
    Highly virulent HIV variant found circulating in Europe.
    Nature. 2022 Feb 3. pii: 10.1038/d41586-022-00317.
    PubMed    
    
    
    
41. 
    Earliest humans, HIV variant and breakthrough COVID.
    Nature. 2022;602:367.
    PubMed    
    
    
    January 2022
42. KEETON R, Tincho MB, Ngomti A, Baguma R, et al
    T cell responses to SARS-CoV-2 spike cross-recognize Omicron.
    Nature. 2022 Jan 31. pii: 10.1038/s41586-022-04460.
    PubMed     Abstract available
    
    
    
43. WANG K, Jia Z, Bao L, Wang L, et al
    Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants.
    Nature. 2022 Jan 28. pii: 10.1038/s41586-022-04466.
    PubMed     Abstract available
    
    
    
44. VIANA R, Moyo S, Amoako DG, Tegally H, et al
    Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.
    Nature. 2022 Jan 7. pii: 10.1038/s41586-022-04411.
    PubMed     Abstract available
    
    
    December 2021
45. CAO Y, Wang J, Jian F, Xiao T, et al
    Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies.
    Nature. 2021 Dec 23. pii: 10.1038/s41586-021-04385.
    PubMed     Abstract available
    
    
    
46. VIDAL SJ, Bekerman E, Hansen D, Lu B, et al
    Long Acting Capsid Inhibitor Protects Macaques From Repeat SHIV Challenges.
    Nature. 2021 Dec 7. pii: 10.1038/s41586-021-04279.
    PubMed     Abstract available
    
    
    
47. MSOMI N, Lessells R, Mlisana K, de Oliveira T, et al
    Africa: tackle HIV and COVID-19 together.
    Nature. 2021;600:33-36.
    PubMed    
    
    
    
48. FAUCI A
    Victories against AIDS have lessons for COVID-19.
    Nature. 2021;600:9.
    PubMed    
    
    
    
49. 
    A fatty molecule shows promise for staving off HIV.
    Nature. 2021;600:572.
    PubMed    
    
    
    November 2021
50. GRAHAM F
    Daily briefing: Second person found to have 'naturally' eradicated HIV.
    Nature. 2021 Nov 18. pii: 10.1038/d41586-021-03489.
    PubMed    
    
    
    March 2021
51. MAXMEN A
    Achilles heel spotted for promising HIV-prevention drug.
    Nature. 2021;591:357-358.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.